Nuclear cardiology and heart failure

Eur J Nucl Med Mol Imaging. 2009 Dec;36(12):2068-80. doi: 10.1007/s00259-009-1246-2.

Abstract

The prevalence of heart failure in the adult population is increasing. It varies between 1% and 2%, although it mainly affects elderly people (6-10% of people over the age of 65 years will develop heart failure). The syndrome of heart failure arises as a consequence of an abnormality in cardiac structure, function, rhythm, or conduction. Coronary artery disease is the leading cause of heart failure and it accounts for this disorder in 60-70% of all patients affected. Nuclear techniques provide unique information on left ventricular function and perfusion by gated-single photon emission tomography (SPECT). Myocardial viability can be assessed by both SPECT and PET imaging. Finally, autonomic dysfunction has been shown to increase the risk of death in patients with heart disease and this may be applicable to all patients with cardiac disease regardless of aetiology. MIBG scanning has a very promising prognostic value in patients with heart failure.

Publication types

  • Review

MeSH terms

  • Cardiology / methods*
  • Diagnostic Imaging
  • Heart Failure / diagnosis*
  • Heart Failure / diagnostic imaging
  • Heart Failure / pathology
  • Heart Failure / physiopathology
  • Humans
  • Nuclear Medicine / methods*
  • Radionuclide Imaging
  • Tissue Survival
  • Ventricular Dysfunction, Left / diagnosis
  • Ventricular Dysfunction, Left / diagnostic imaging
  • Ventricular Dysfunction, Left / pathology
  • Ventricular Dysfunction, Left / physiopathology